Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

RenovoRx (RNXT) Enterprise Value (2024 - 2025)

Historic Enterprise Value for RenovoRx (RNXT) over the last 2 years, with Q3 2025 value amounting to -$10.0 million.

  • RenovoRx's Enterprise Value fell 462.5% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.0 million, marking a year-over-year decrease of 462.5%. This contributed to the annual value of -$7.2 million for FY2024, which is N/A changed from last year.
  • Per RenovoRx's latest filing, its Enterprise Value stood at -$10.0 million for Q3 2025, which was down 462.5% from -$12.3 million recorded in Q2 2025.
  • In the past 5 years, RenovoRx's Enterprise Value registered a high of -$4.4 million during Q1 2024, and its lowest value of -$14.6 million during Q1 2025.